From my understanding as @mohdrehan1 has said the company is mainly into regulated markets. Lets look at Ibuprofen. It is a pretty generic drug which it is sold over the market in US. From my understanding penetrating the OTC markets in US is not an easy task. The major brands in Ibuprofen are Advil and Motrin by Pfizer and Johnson & Johnson. Advil is a billion dollar brand. Then why is is it that Indian manufacturers doesn’t have a large share in this market. Its because its not easy to penetrate the OTC market. OTC medicines are usually sold through supermarkets and phramacies like walmart, costco, walgreen etc or through e commerce companies. Its not easy to get shelf space in stores. Usually they have brands from large firms and store brands. Marksans acquired Timecap in 2014 and it may not have been easy for them to build the network they have now. Having a frontline marketing and manufacturing firm in US may one of the reasons for their success in the OTC market. They also make Ibuprofen in private label for walgreen I believe. So once they have this reach, it makes it easier for them to launch new drugs in the OTC market. I think they had the same idea with Relonchem, Bell and Nova pharmaceuticals. They are trying to do the same in Europe. That why they are scouting for a frontline marketing company there.
Subscribe To Our Free Newsletter |